iHuman
5 hedge funds and large institutions have $8.47M invested in iHuman in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
32% more capital invested
Capital invested by funds: $6.43M → $8.47M (+$2.04M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
0.01% less ownership
Funds ownership: 2.15% → 2.14% (-0.01%)
29% less funds holding
Funds holding: 7 → 5 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$6.49K |
| 2 |
Renaissance Technologies
New York
|
+$644 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$29.3K |
| 2 |
Morgan Stanley
New York
|
-$13.8K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$6.16K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$4.25K |
IH Hedge Fund Activity: Q1 2023 in Review
5 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in iHuman (IH) for Q1 2023, worth a combined $8.47M — up 32% from $6.43M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of IH and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 2 added.
The largest buyer was State Street, adding an estimated $6.49K. The largest seller was Anson Funds Management, exiting entirely with an estimated $29.3K sold.
- 5 institutional investors held iHuman (IH) as of Q1 2023, down from 7 in Q4 2022.
- Funds reported $8.47M of iHuman stock for Q1 2023, up 32% quarter-over-quarter.
- 0 funds opened new iHuman positions in Q1 2023 and 2 closed out, a net change of -2 holders.
- The largest iHuman buyer in Q1 2023 was State Street, an estimated $6.49K added.
- The largest iHuman seller in Q1 2023 was Anson Funds Management, an estimated $29.3K sold.
Based on aggregated 13F filings for Q1 2023.